Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03099954 · ClinicalTrials.gov registry record
Withings Pulse Wave Velocity and Blood Pressure Study
A clinical trial, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- 300
- Enrollment target
NCT03099954: Completed study, sponsored by Scripps Translational Science Institute.
NCT03099954 is a clinical trial that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03099954 has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
Measure pulse wave velocity stability in relation to time of day, day of the week, physical activity, sleep quality, stress levels and blood pressure.
Primary Outcome
The study population will be an estimated 300 healthy adult subjects from the United States who own a Withings blood pressure cuff, Withings activity tracker, and Withings Body Cardio scale and have measured their blood pressure at least once per week for the majority of weeks over the last three months.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2017-01-19 |
| Est. Completion | 2017-10-31 |
What the finished NCT03099954 record still lists
NCT03099954 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03099954 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03099954 about?
NCT03099954 is a clinical study titled "Withings Pulse Wave Velocity and Blood Pressure Study". Measure pulse wave velocity stability in relation to time of day, day of the week, physical activity, sleep quality, stress levels and blood pressure.
What is the current status of trial NCT03099954?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2017-01-19. Estimated completion is 2017-10-31.
Who is sponsoring clinical trial NCT03099954?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI